Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America (Q33894467)

29 July 2017

0 references

Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America (English)

1 reference

29 July 2017

1 reference

3

Sobel JD

1 reference

29 July 2017

Rex JH

1

1 reference

29 July 2017

Walsh TJ

2

1 reference

29 July 2017

Filler SG

4

1 reference

29 July 2017

Pappas PG

5

1 reference

29 July 2017

Dismukes WE

6

1 reference

29 July 2017

Edwards JE

7

1 reference

29 July 2017

language of work or name

English

0 references

publication date

20 April 2000

1 reference

Clinical Infectious Diseases

29 July 2017

published in

1 reference

29 July 2017

volume

30

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

662-678

1 reference

Infectious Disease Society of America

29 July 2017

0 references

issuing agent of work

0 references

cites work

National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathog

1 reference

21 January 2018

1 reference

Detection of amphotericin B-resistant Candida isolates in a broth-based system

21 January 2018

1 reference

Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group

21 January 2018

1 reference

Antifungal activity of a new triazole, D0870, compared with four other antifungal agents tested against clinical isolates of Candida and Torulopsis glabrata

21 January 2018

1 reference

Patterns of in vitro activity of itraconazole and imidazole antifungal agents against Candida albicans with decreased susceptibility to fluconazole from Spain

21 January 2018

1 reference

Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates

21 January 2018

1 reference

Comparison of in vivo activity of fluconazole with that of amphotericin B against Candida tropicalis, Candida glabrata, and Candida krusei

21 January 2018

1 reference

Strain delineation and antifungal susceptibilities of epidemiologically related and unrelated isolates of Candida lusitaniae.

21 January 2018

1 reference

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te

21 January 2018

1 reference

A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance

21 January 2018

1 reference

Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

21 January 2018

1 reference

Amphotericin B Colloidal Dispersion for Treatment of Candidemia in Immunocompromised Patients

21 January 2018

1 reference

Lipid formulations of amphotericin B: recent progress and future directions

21 January 2018

1 reference

Antifungal agents in neonatal systemic candidiasis

21 January 2018

1 reference

Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life

21 January 2018

1 reference

Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses

21 January 2018

1 reference

Practice guidelines for the treatment of fungal infections. For the Mycoses Study Group. Infectious Diseases Society of America

21 January 2018

1 reference

A pharmacokinetic study of intravenous itraconazole followed by oral administration of itraconazole capsules in patients with advanced human immunodeficiency virus infection

21 January 2018

1 reference

Emergence of Candida parapsilosis as the predominant species causing candidemia in children

21 January 2018

1 reference

Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases

21 January 2018

1 reference

International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections

21 January 2018

1 reference

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America

21 January 2018

1 reference

Candida colonization and subsequent infections in critically ill surgical patients

21 January 2018

1 reference

Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality

21 January 2018

1 reference

Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

21 January 2018

1 reference

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

21 January 2018

1 reference

Successful treatment of hepatosplenic candidiasis through repeated cycles of chemotherapy and neutropenia

21 January 2018

1 reference

Hepatosplenic candidiasis: successful treatment with fluconazole

21 January 2018

1 reference

Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy

21 January 2018

1 reference

Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy

21 January 2018

1 reference

Fungicidal effect of amphotericin B in urine: in vitro study to assess feasibility of bladder washout for localization of site of candiduria

21 January 2018

1 reference

Pulmonary disease caused by Candida species

21 January 2018

1 reference

Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study

21 January 2018

1 reference

Spondylodiskitis due to Candida albicans: report of two patients who were successfully treated with fluconazole and review of the literature

21 January 2018

1 reference

Successful treatment of Candida albicans osteomyelitis with fluconazole

21 January 2018

1 reference

Candida tropicalis arthritis in a patient with acute myeloid leukemia successfully treated with fluconazole: case report and review of the literature.

21 January 2018

1 reference

Candida prosthetic arthritis: report of a case treated with fluconazole and review of the literature

21 January 2018

1 reference

Candidal Mediastinitis: An Emerging Clinical Entity

21 January 2018

1 reference

Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes

21 January 2018

1 reference

Fungal peritonitis in patients on peritoneal dialysis

21 January 2018

1 reference

Candida peritonitis. Report of 22 cases and review of the English literature

21 January 2018

1 reference

Clinical significance of Candida isolated from peritoneum in surgical patients

21 January 2018

1 reference

Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients.

21 January 2018

1 reference

Purulent Pericarditis Caused by Candida Species: Case Report and Review

21 January 2018

1 reference

Candida septic thrombosis of the great central veins associated with central catheters. Clinical features and management

21 January 2018

1 reference

Management of Septic Thrombosis of the Inferior Vena Cava Caused by Candida

21 January 2018

1 reference

Late recurrent Candida endocarditis

21 January 2018

1 reference

Candida pericarditis: clinical profile and treatment

21 January 2018

1 reference

Candidal sepsis and meningitis in a very-low-birth-weight infant successfully treated with fluconazole and flucytosine

21 January 2018

1 reference

Meningitis caused by Candida species: an emerging problem in neurosurgical patients

21 January 2018

1 reference

Use of fluconazole in the treatment of candidal endophthalmitis.

21 January 2018

1 reference

Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance

21 January 2018

1 reference

A comparative study of the efficacy of fluconazole and amphotericin B in the treatment of oropharyngeal candidosis in patients undergoing radiotherapy for head and neck tumours

21 January 2018

1 reference

Itraconazole solution: higher serum drug concentrations and better clinical response rates than the capsule formulation in acquired immunodeficiency syndrome patients with candidosis

21 January 2018

1 reference

Fluconazole suspension for oropharyngeal candidiasis unresponsive to tablets.

21 January 2018

1 reference

A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group

21 January 2018

1 reference

Value of antifungal prophylaxis with antifungal drugs against oropharyngeal candidiasis in cancer patients

21 January 2018

1 reference

Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group

21 January 2018

1 reference

Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis

21 January 2018

1 reference

Clinical and mycological evaluation of fluconazole in the secondary prophylaxis of esophageal candidiasis in AIDS patients. An open, multicenter study.

21 January 2018

1 reference

Refractory Mucosal Candidiasis in Patients with Human Immunodeficiency Virus Infection

21 January 2018

1 reference

Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients.

21 January 2018

1 reference

Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole

21 January 2018

1 reference

Activity of terbinafine in experimental fungal infections of laboratory animals

21 January 2018

1 reference

New approaches to the treatment of onychomycosis

21 January 2018

1 reference

Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients.

21 January 2018

1 reference

Treatment options for vulvovaginal candidiasis, 1993.

21 January 2018

1 reference

Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy

21 January 2018

1 reference

Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations.

21 January 2018

1 reference

Symptomatic vulvovaginitis due to fluconazole-resistant Candida albicans in a female who was not infected with human immunodeficiency virus

21 January 2018

1 reference

Recurrent vulvovaginal candidiasis. A prospective study of the efficacy of maintenance ketoconazole therapy.

21 January 2018

1 reference

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

21 January 2018

1 reference

Candida albicansEndophthalmitis in Brown Heroin Addicts: Response to Early Vitrectomy Preceded and Followed by Antifungal Therapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/313749

1 reference

29 July 2017

1 reference